Skip to main content
Log in

A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes

  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Objective: To ascertain the correlation between visual acuity levels and ophthalmic utility values obtained using time tradeoff and standard gamble utility analysis methodologies. Methods: Three hundred twenty-five consecutive patients with visual loss to 20/40 or less in at least one eye with predominantly vitreoretinal pathology were evaluated in a cross-sectional fashion using a standardized testing methodology to obtain ophthalmic time tradeoff and standard gamble utility values. Spearman correlation coefficients were employed to correlate the utility values with visual acuity in better seeing and poorer seeing eyes. Results: The Spearman correlation coefficient for time tradeoff utility values and vision in the better seeing eye was 0.455 (p < 0.001), while that for time tradeoff utility values and visual acuity in the poorer seeing eye was 0.268 (p < 0.001). The coefficient for standard gamble utility values and the better seeing eye was 0.371 (p < 0.001), while that for standard gamble utility values and vision in the poorer seeing eye was 0.250 (p < 0.001). Conclusions: There is a greater correlation between ophthalmic utility values and vision in the better seeing eye, as versus vision in the poorer seeing eye. Time tradeoff ophthalmic utility values demonstrate a greater correlation with vision in the better seeing eye than do standard gamble utility values.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wang JJ, Mitchell P, Smith W. Vision and low self-rated health: the Blue Mountains Eye Study. Invest Ophthalmol 2000; 41: 49–54.

    Google Scholar 

  2. Lee P. Smith JP, Kingston R. The relationship of self-rated vision and hearing to functional status and well-being among seniors 70 years and older. Am J Ophthalmol 1999; 127: 447–452.

    PubMed  Google Scholar 

  3. Rubin GS, Bandeen-Roche K, Huang G, Munoz B, Schein OD, Fried LP. West SK. The association of multiple visual impairments with self-reported visual disability: SEE project. Invest Ophthalmol Vis Sci 2001; 42: 64–72.

    PubMed  Google Scholar 

  4. Redelmeier DA, Detsky AS. A clinician's guide to utility measurement. Med Decis Making 1995; 22: 271–280.

    Google Scholar 

  5. Torrance GW. Measurement of health state utilities for economic appraisal. A review. J Health Econ 1986; 5: 1–30.

    PubMed  Google Scholar 

  6. Brown MM, Brown GC, Sharma S, Garrett S. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol 1999; 10: 221–226.

    PubMed  Google Scholar 

  7. Brown GC, Brown MM, Sharma S. Health care in the 21st century. Evidence-based medicine, patient preference-based quality and cost-effectiveness. Quality Management in Health Care 2000; 19: 23–31.

    Google Scholar 

  8. Brown GC, Brown MM, Sharma S. Quality and cost-effectiveness in health care: A unique approach. J Ophthalmic Nursing & Technology 2000; Jan-Feb: 26–30.

  9. Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc 1999; 92: 474–511.

    Google Scholar 

  10. Brown MM, Brown GC, Sharma S, Kistler J. Utility values associated with age-related macular degeneration. Arch Ophthalmol 2000; 118: 47–51.

    PubMed  Google Scholar 

  11. Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol 2001; 85: 327–331.

    PubMed  Google Scholar 

  12. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999; 128: 324–330.

    PubMed  Google Scholar 

  13. Nease RF, Whitcup SM, Ellwein LB, Fox G, Littenberg B. Utility-based estimates of the relative morbidity of visual impairment and angina. Ophthalmic Epidemiology 2000; 7: 169–185.

    PubMed  Google Scholar 

  14. Linder M, Chang TS, Scott IU, Hay D, Chambers K, Sibley LM, Weis E. Validity of the visual function index (VF-14) in patients with retinal disease. Arch Ophthalmol 1999; 117: 1611–1616.

    PubMed  Google Scholar 

  15. Bass EB, Wills S, Scott IU, Javitt JC, Tielsch JM, Schein OD, Steinberg EP. Preference values for visual states in patients planning to undergo cataract surgery. Med Decis Making 1997; 17: 324–330.

    PubMed  Google Scholar 

  16. Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, Cassard SD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 1994; 112: 630–638.

    PubMed  Google Scholar 

  17. Westheimer G. Scaling of visual acuity measurements. Arch Ophthalmol 1979; 97: 327–330.

    PubMed  Google Scholar 

  18. Rosser DA, Laidlow PA, Murdoch IE. The development of a “reduced logMAR” visual acuity for use in routine clinical practice. Br J Ophthalmol 2001; 85: 432–436.

    PubMed  Google Scholar 

  19. Norusis MJ. SPSS 9.0 Guide to Data Analysis. Upper Saddle River, NJ, Prentice Hall, 1999, pp. 349–371.

    Google Scholar 

  20. Rubin GS, Munoz B, Bandeen-Roche K, West SK. Monocular versus binocular visual acuity as measures of vision impairment and predictors of visual disability. Invest Ophthalmol Vis Sci 2000; 41: 3327–3334.

    PubMed  Google Scholar 

  21. Cagenello R, Arditi A, Halpern DL. Binocular enhancement of visual acuity. J Opt Soc Am A 1993; 10: 1841–1848.

    Google Scholar 

  22. Mosely MJ, Jones HS. Visual acuity: Calculating appropriate averages. Acta Ophthalmol 1993; 71: 296–300.

    Google Scholar 

  23. Guyatt GH. A taxonomy of health status instruments. J Rheumatol 1995; 22: 1188–1190.

    PubMed  Google Scholar 

  24. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622–629.

    PubMed  Google Scholar 

  25. Hollands H, Lam M, Pater J, Albiani D, Brown GC, Brown MM, Cruess AF, Sharma S. Reliability of the time trade-off technique of utility assessment in patients with retinal disease. Can J Ophthalmol 2001; 36: 202–209.

    PubMed  Google Scholar 

  26. Rosner B. Fundamentals of Biostatistics, 5th edn., United States, Duxbury Thomson Learning, 2000, pp. 562–567.

    Google Scholar 

  27. Smith A, Brown GC. Understanding cost-effectiveness: a detailed review. Br J Ophthalmol 2000; 54: 794–798.

    Google Scholar 

  28. Brown GC, Brown MM, Sharma S, Busbee, Brown H. Incremental cost-effectiveness of laser photocoagulation for choroidal neovascularization associated with histoplasmosis. RETINA 2000; 20: 331–337.

    PubMed  Google Scholar 

  29. Brown GC, Brown MM, Sharma S. Incremental costeffectiveness of laser therapy for subfoveal choroidal neovascularization. Ophthalmology 2000; 107: 1374–1380

    PubMed  Google Scholar 

  30. Wakker P, Stiggelbout A. Explaining distortions in utility elicitation through the rank-dependent model for risky choices. Med Decis Making 1995; 15: 180–186.

    PubMed  Google Scholar 

  31. Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes. Comparison of assessment methods. Med Decis Making 1984; 4: 315–329.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brown, M.M., Brown, G.C., Sharma, S. et al. A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes. Int Ophthalmol 24, 123–127 (2001). https://doi.org/10.1023/A:1021171000838

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021171000838

Keywords

Navigation